220074-38-4 Usage
Usage
Control of pests and insects in agricultural and household settings
Mechanism of action
Inhibition of the enzyme acetylcholinesterase, leading to disruption in nerve function, paralysis, and death of target organisms
Toxicity
Toxic to humans and non-target organisms, requires caution and care in use
Chemical structure
Contains a carbamate functional group and a 1,1-dimethylethyl group
Physical properties
Likely a liquid or solid at room temperature, specific properties depend on the compound's molecular structure and size
Environmental impact
Potential for contamination of soil and water if not used properly, may have negative effects on non-target organisms and ecosystems
Regulatory status
May be subject to restrictions or regulations depending on the country or region, due to its toxicity and potential environmental impact.
Check Digit Verification of cas no
The CAS Registry Mumber 220074-38-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,0,0,7 and 4 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 220074-38:
(8*2)+(7*2)+(6*0)+(5*0)+(4*7)+(3*4)+(2*3)+(1*8)=84
84 % 10 = 4
So 220074-38-4 is a valid CAS Registry Number.
220074-38-4Relevant articles and documents
ALK5 INHIBITOR CONJUGATES AND USES THEREOF
-
Paragraph 0158-0160, (2021/07/17)
The present disclosure relates to targeted drug conjugates comprising ALK5 inhibitors and targeting moieties that direct the ALK5 inhibitors to cells involved in fibrosis and cancer, for example myofibroblasts, activated fibroblasts and transitioning fibr
ALK5 INHIBITORS
-
, (2020/07/07)
The present disclosure provides inhibitors of activin receptor-like kinase 5 (ALK5). Also disclosed are methods to modulate the activity of ALK5 and methods of treatment of disorders mediated by ALK5.
ANTIBODY-ALK5 INHIBITOR CONJUGATES AND THEIR USES
-
Paragraph 0166-0168, (2020/06/07)
The present disclosure relates to antibody-drug conjugates comprising ALK5 inhibitors and their uses.
